On March 14, Shan Dong Kexing Bioproducts Co.Ltd(688136) announced that the company invested abroad to set up a holding subsidiary, Shenzhen Kexing animal protection Biotechnology Co., Ltd., whose business scope is animal vaccine research and development.
According to the announcement, Shan Dong Kexing Bioproducts Co.Ltd(688136) signed the cooperation agreement on the joint venture establishment of Shenzhen Kexing animal protection Biotechnology Co., Ltd. with Fu Jun and Ma Jingyun, Shan Dong Kexing Bioproducts Co.Ltd(688136) , Fu Jun and Ma Jingyun jointly invested in the establishment of Shenzhen Kexing animal protection Biotechnology Co., Ltd. Shan Dong Kexing Bioproducts Co.Ltd(688136) contributed 6 million yuan in cash, subscribed 6 million yuan in the registered capital of the joint venture and held 550005% shares; Fu Jun and Ma Jingyun subscribed 4.909 million yuan of the registered capital of the joint venture with intangible assets, with a total shareholding of 449995%.
The announcement said that this foreign investment is to carry out research and development activities related to animal vaccines, make full use of the company’s rich experience and advantageous position in the field of biomedicine, seize the opportunity of biotechnology development, promote the company’s overall development strategy, better optimize the company’s resource allocation and enhance the company’s core competitiveness.
